Creative Medical Technology Holdings, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Creative Medical Technology Holdings, Inc. (CELZ) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $0 for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2020-08-14
- Creative Medical Technology Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2020-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2019-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2015 was -$30.76K.
- Creative Medical Technology Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2014 was -$28.01K.
- Creative Medical Technology Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2013 was -$27.28K.
- Creative Medical Technology Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2012 was -$25.59K.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|---|
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | |
| 2015-12-31 | -$30.76K 10-K · filed 2016-04-14 | ||
| 2014-12-31 | -$28.01K 10-K · filed 2016-04-14 | ||
| 2013-12-31 | -$27.28K 10-K · filed 2015-02-27 | ||
| 2012-12-31 | -$25.59K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |